Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback